Manolo Carta

Cagliari, 09042, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.

Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.

Journal: Neurochemical research

Published: July 25, 2025

Pregnenolone Reduces L-Dopa-Induced Dyskinesias in Female Parkinsonian Monkeys.

Pregnenolone Reduces L-Dopa-Induced Dyskinesias in Female Parkinsonian Monkeys.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 12, 2025

Effect of 5-alpha reductase inhibitors in animal models of Parkinson's disease.

Effect of 5-alpha reductase inhibitors in animal models of Parkinson's disease.

Journal: Frontiers in neuroendocrinology

Published: June 03, 2024

Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.

Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.

Journal: Neuroscience and biobehavioral reviews

Published: May 23, 2024

The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease.

The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease.

Journal: Journal of neurology

Published: February 03, 2024

Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].

Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].

Journal: Experimental neurology

Published: December 16, 2023

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy.

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy.

Journal: Communications biology

Published: May 03, 2023

Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration.

Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration.

Journal: Neurobiology of disease

Published: April 27, 2023

Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.

Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.

Journal: Neurobiology of disease

Published: April 27, 2023

Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.

Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.

Journal: Experimental neurology

Published: September 30, 2022

Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy.

Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy.

Journal: Biomolecules

Published: August 30, 2022

Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update.

Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update.

Journal: Progress in brain research

Published: March 31, 2021

Showing 1-12 of 46

Last Updated: 09/26/2026